Stockscreener 앱 받기
0.5468
10.42%
-0.0637
Clearmind Medicine Inc 주식(CMND)의 최신 뉴스
Clearmind files European patent for PTSD treatment compounds By Investing.com - Investing.com South Africa
Clearmind files European patent for PTSD treatment compounds - Investing.com UK
Clearmind Medicine Inc. Files European Patent Application for Innovative Psychedelic Compounds Targeting PTSD Treatment - Quiver Quantitative
Clearmind (Nasdaq: CMND) files European patent for PTSD psychedelics - Stock Titan
Clearmind Medicine Announces Filing Of European Patent Application For Novel Psychedelic Compounds For The Treatment Of Ptsd - TradingView
Clearmind seeks European patent for psychedelic PTSD compounds - Stock Titan
Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic ... - Caledonian Record
Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic Compounds for the Treatment of PTSD - marketscreener.com
CMND Stock Price, Quote & Chart | CLEARMIND MEDICINE INC (NASDAQ:CMND) - ChartMill
Clearmind Medicine (NASDAQ: CMND) registers 22.6M resale shares tied to $10M notes - Stock Titan
Clearmind Medicine amends securities agreement and announces board changes - Investing.com
Leadership shifts at Clearmind Medicine (NASDAQ: CMND) as chair exits - Stock Titan
Clearmind shares surge as CMND-100 achieves primary endpoint in clinical trial - MSN
Clearmind Announces Changes To Senior Management As It Accelerates Development Of Its IP Portfolio - TMX Newsfile
Clearmind Medicine regains compliance with Nasdaq - MSN
Clearmind Medicine to enact 1-for-40 reverse share split; shares down - MSN
Clearmind Medicine Announces Evaluation of its Psychedelic-Based Treatment (MEAI) for Potential FDA Breakthrough Therapy Designation - The Manila Times
Clearmind Medicine Inc. Pursues Breakthrough Therapy Designation for Alcohol Use Disorder Treatment CMND-100 Following Positive Clinical Trial Results - Quiver Quantitative
Clearmind (NASDAQ: CMND) explores FDA breakthrough path for CMND-100 in AUD - Stock Titan
Alcohol disorder treatment from Clearmind eyes FDA breakthrough path - Stock Titan
CMND stock set for biggest intraday gains in over three years — here’s why retail is eyeing further upside - MSN
Clearmind Medicine Inc. (CMND) Stock Price Today - MEXC Exchange
CMND Technical Analysis | Trend, Signals & Chart Patterns | CLEARMIND MEDICINE INC (NASDAQ:CMND) - ChartMill
Why is Clearmind Medicine stock sliding on Wednesday? - MSN
Why Is Clearmind Medicine Stock Sliding On Wednesday? - Benzinga
Crude Oil Surges Over 6%; Investar Holding Shares Gain Following Q1 Earnings - Sahm
US Stocks Mixed; Cleveland-Cliffs Shares Fall After Q1 Results - Sahm
Clearmind Medicine (NASDAQ: CMND) adds $2.7M notes and converts $2.68M to shares - Stock Titan
Dow Gains Over 200 Points; US Retail Sales Top Estimates - Sahm
Clearmind’s CMND-100 meets primary endpoint in phase I/IIa trial - Investing.com India
Clearmind Medicine (CMND) issues $2.7M in new convertible promissory notes at 90% of principal - Stock Titan
Clearmind Medicine (CMND) Stock Surges 100% After Drug Trial Hit Safety Goals - MEXC Exchange
Clearmind Medicine Welcomes President Trump’s Executive Order as a Historic Catalyst for Psychedelic Innovation and Veteran Mental Health Care - The Manila Times
[6-K] Clearmind Medicine Inc. Current Report (Foreign Issuer) | CMND SEC FilingForm 6-K - Stock Titan
Trump order spotlights psychedelic drugs for veterans, Clearmind says - Stock Titan
Clearmind’s CMND-100 meets primary endpoint in phase I/IIa trial By Investing.com - Investing.com South Africa
CMND Stock Jumps As Psychedelic Tailwinds Lift Clearmind - StocksToTrade
Clearmind Medicine jumps 64.7% after CMND-100 hits key safety endpoint in early AUD study - Quiver Quantitative
Clearmind Medicine's CMND-100 Achieves Key Safety Milestone in Alcohol Use Disorder Trial: What U.S. - AD HOC NEWS
Clearmind Medicine Says Drug Candidate Met Primary Endpoint in Phase I/IIa Trial to Treat Alcohol Use Disorder - Moomoo
Clearmind Medicine (CMND) Stock Doubles as CMND-100 Passes Critical Safety Milestone - Blockonomi
Why Is Clearmind Stock Rising Monday?Clearmind Medicine (NASDAQ:CMND) - Benzinga
Clearmind Medicine CMND Stock Jumps On Psychedelic Policy Tailwinds - timothysykes.com
0.78%
3.01%
자본화:
|
볼륨(24시간):